Article

AMO pledges $1 million to support research in refractive lenticular science

Advanced Medical Optics (AMO) announced it will pledge $1 million to support independent research/programming in refractive lenticular science sponsored by the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. I. Howard Fine, MD, ASCRS foundation chairman, announced the AMO grant during the opening general session Saturday morning.

Advanced Medical Optics (AMO) announced it will pledge $1 million to support independent research/programming in refractive lenticular science sponsored by the American Society of Cataract and Refractive Surgery (ASCRS) Foundation. I. Howard Fine, MD, ASCRS foundation chairman, announced the AMO grant during the opening general session Saturday morning.

"In 2006, we will begin work on a substantial multi-year program to support new research and new educational programs that explore the rapidly emerging science of refractive lenticular surgery," Dr. Fine said. "In the coming years, the ever-increasing merger of cataract and laser refractive science will change our practices and greatly increase what we can offer our patients."

AMO President and Chief Executive Officer James V. Mazzo commended the ASCRS Foundation for its foresight and leadership in forming this effort to advance refractive corneal and lenticular research and education.

"We hope that other industry participants will join AMO and offer their resources and support to the ASCRS Foundation to ensure the program's sustained success," Mazzo said.

The ASCRS Foundation - supported by unrestricted donations from ASCRS members and the ophthalmic industry - funds ophthalmic research, public education, and charitable activities in the developing world.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.